Intramuscular epinephrine as first-line treatment of anaphylaxis: still concerns about its safety in the elderly?
Abstract
Anaphylaxis is a severe condition that can affect patients of all ages. Elderly patients must be considered
particularly vulnerable to severe anaphylaxis due to many risk factors such as concomitant diseases and medications.
Intramuscular administration of epinephrine is recommended as fist-line therapy for anaphylaxis and
its use should be promoted in every setting. Intramuscular epinephrine is recognized as generally safe and
there are no absolute contraindications to the prescription of self-injectable adrenaline in older patients at risk
of anaphylaxis.
Affiliations
License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Copyright
© Società Italiana di Gerontologia e Geriatria (SIGG) , 2018
How to Cite
- Abstract viewed - 196 times
- PDF downloaded - 95 times